Effectiveness and safety of apixaban and warfarin in patients with new- onset atrial fibrillation after advanced chronic kidney disease or end-stage kidney disease
Authors:
- Hsin-Hua ChenHCHsin-Hua Chen
- Shang-Feng TsaiShang-Feng Tsai
- 8 February 2025
- journal article
- Published by Elsevier in Heart Rhythm
- Vol. 22 (5) , 1197-1209
Abstract
No abstract availableKeywords
Funding Information
- Kaohsiung Veterans General Hospital (SE22220A-1)
- Taichung Veterans General Hospital
This publication has 41 references indexed in Scilit:
- Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and stage 5 chronic kidney disease under dialysis: A systematic review and meta-analysis of randomized controlled trialsJournal of Thrombosis and Thrombolysis, 2024
- Thoracic aortic aneurysm and atrial fibrillation: clinical associations with the risk of stroke from a global federated health network analysisInternal and Emergency Medicine, 2023
- Safety and effectiveness of apixaban versus warfarin for acute venous thromboembolism in patients with end‐stage kidney disease: A national cohort studyJournal of Hospital Medicine, 2022
- Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysisIndian Pacing and Electrophysiology Journal, 2021
- Effect of Rivaroxaban or Apixaban in Atrial Fibrillation Patients with Stage 4–5 Chronic Kidney Disease or on DialysisCardiovascular Drugs and Therapy, 2021
- Anticoagulation for Stroke Prevention in Patients With Atrial Fibrillation and End-Stage Renal Disease—First, Do No HarmJAMA Network Open, 2020
- Safety and effectiveness of apixaban compared to warfarin in dialysis patientsResearch and Practice in Thrombosis and Haemostasis, 2018
- The Quandary of Oral Anticoagulation in Patients With Atrial Fibrillation and Chronic Kidney DiseaseThe American Journal of Cardiology, 2016
- Warfarin, Calciphylaxis, Atrial Fibrillation, and Patients on Dialysis: Outlier Subsets and Practice GuidelinesThe American Journal of Medicine, 2014
- Trends in Anticoagulation for Atrial Fibrillation in the U.S.JACC, 2007